NFKB1 and non-small cell lung carcinoma: Mechanistically, TOPN upregulates PD-L1 expression in NSCLC cells via activation of the NF-κB signaling pathway, and in vivo models confirmed that TOPN-induced PD-L1 facilitates tumor progression (128).